The emergence of e-cigarettes in the tobacco product landscape has shifted clinical and public health approaches to tobacco prevention and control. While much is known about e-cigarettes, many questions remain about their health and public health implications.
In this webinar, participants will gain an understanding about what e-cigarettes are, who is using e-cigarettes and why, and what current evidence we have regarding the health impact of e-cigarette use. Clinical and public health approaches to e-cigarettes and other emerging tobacco products will additionally be discussed.
Presented by: Brenna VanFrank, MD, MPH
Disclosures: None
The emergence of e-cigarettes in the tobacco product landscape has shifted clinical and public health approaches to tobacco prevention and control. While much is known about e-cigarettes, many questions remain about their health and public health implications.
In this webinar, participants will gain an understanding about what e-cigarettes are, who is using e-cigarettes and why, and what current evidence we have regarding the health impact of e-cigarette use. Clinical and public health approaches to e-cigarettes and other emerging tobacco products will additionally be discussed.
Learning Objectives:
- Identify the types of e-cigarettes and the substances they contain
- Describe e-cigarette use patterns and the potential health impacts of e-cigarette use
- Understand clinical and public health approaches to emerging tobacco products
An application has been made to Creighton University Health Sciences Continuing Education (HSCE) for 1.0 CNE credit hour.This course has been approved for 1.0 AACVPR CE credit hour.
| Title | Credit(s) | |
|---|---|---|
| 1 | ||
| 2 | ||
| 3 | ||
| 4 |